Purdue Pleads Guilty to Mislabeling OxyContin

Drug Industry Daily
A A
Purdue Pharma and three current and former company executives pleaded guilty to mislabeling OxyContin and will pay more than $634 million in fines, according to a U.S. prosecutor.

To View This Article:

Login

Subscribe To Drug Industry Daily